Gene · 7409
Papers3,486
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 3,486
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of N6-Methyladenosine (m6A) Methylation Modifications in Hematological Malignancies. | Cancers (Basel) | 2022 | 35053496 | PubTator, text mining | PubMed |
| Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways. | Cells | 2022 | 35053339 | PubTator, text mining | PubMed |
| Proteomic identification of new diagnostic biomarkers of early-stage cutaneous mycosis fungoides. | Cancer Commun (Lond) | 2022 | 35049132 | PubTator, text mining | PubMed |
| TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity. | Cell Stem Cell | 2022 | 35045331 | PubTator, text mining | PubMed |
Integration of gene co-expression analysis and multi-class SVM specifies the functional players involved in determining the fate of HTLV-1 infection toward the development of cancer (ATLL) or neurological disorder (HAM/TSP). | PLoS One | 2022 | 35041720 | PubTator, text mining | PubMed |
| Wnt activation promotes memory T cell polyfunctionality via epigenetic regulator PRMT1. | J Clin Invest | 2022 | 35040433 | PubTator, text mining | PubMed |
| SILAC Phosphoproteomics Reveals Unique Signaling Circuits in CAR-T Cells and the Inhibition of B Cell-Activating Phosphorylation in Target Cells. | J Proteome Res | 2022 | 35014847 | PubTator, text mining | PubMed |
| New insights into aging-associated characteristics of female subcutaneous adipose tissue through integrative analysis of multi-omics data. | Bioengineered | 2022 | 35001792 | PubTator, text mining | PubMed |
| Research progress of the application of mesenchymal stem cells in chronic inflammatory systemic diseases. | Stem Cell Res Ther | 2022 | 34998430 | PubTator, text mining | PubMed |
| Screening and analysis of RNAs associated with activated memory CD4 and CD8 T cells in liver cancer. | World J Surg Oncol | 2022 | 34980144 | PubTator, text mining | PubMed |
| Unraveling unique and common cell type-specific mechanisms in glioblastoma multiforme. | Comput Struct Biotechnol J | 2022 | 34976314 | PubTator, text mining | PubMed |
| Class I Myosins, molecular motors involved in cell migration and cancer. | Cell Adh Migr | 2022 | 34974807 | PubTator, text mining | PubMed |
| Neutrophil cytosolic factor 2 (NCF2) gene polymorphism is associated with juvenile-onset systemic lupus erythematosus, but probably not with other autoimmune rheumatic diseases in children. | Mol Genet Genomic Med | 2022 | 34971477 | PubTator, text mining | PubMed |
| Pathogenesis and virulence of Candida albicans. | Virulence | 2022 | 34964702 | PubTator, text mining | PubMed |
| Sodium stibogluconate and CD47-SIRPα blockade overcome resistance of anti-CD20-opsonized B cells to neutrophil killing. | Blood Adv | 2022 | 34942000 | PubTator, text mining | PubMed |
| The pediatric common variable immunodeficiency - from genetics to therapy: a review. | Eur J Pediatr | 2022 | 34939152 | PubTator, text mining | PubMed |
| Transgenerational effects on the fecundity and sperm proteome in rats exposed to a mixture of pyrethroids at doses similar to human consumption. | Chemosphere | 2022 | 34896426 | PubTator, text mining | PubMed |
| Transient exposure of a buried phosphorylation site in an autoinhibited protein. | Biophys J | 2022 | 34864046 | PubTator, text mining | PubMed |
| PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia. | Blood | 2022 | 34788382 | PubTator, text mining | PubMed |
| SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity. | Cell Immunol | 2022 | 34773897 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7409/papers?page=29